Faculty

Click the links below to find more information:


University Heart Grand OpeningZippity Doo Dah gives to BCHTomorrow. Every Day.Jackson Free Clinic
  • James Rowlett, PhD

    Rowlett, James_2013 Psy web.jpgProfessor
    Psychiatry and Human Behavior  

    Education

    • BA – Morehead State University, psychology, 1988
    • PhD – University of Kentucky, psychology, 1993

    Background

    • Postdoctoral training, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 1993-97
    • Instructor in Psychobiology, Department of Psychiatry & Core Scientist, New England Primate Research Center, Harvard Medical School, 1997-99
    • Assistant Professor of Psychobiology, Department of Psychiatry, Beth Israel Deaconess Medical Center & Core Scientist, New England Primate Research Center, Harvard Medical School, 1999-2007
    • Associate Professor of Psychiatry, Department of Psychiatry, Beth Israel Deaconess Medical Center & Co-Director, Laboratory of Behavioral Biology, Division of Neuroscience, New England Primate Research Center, Harvard Medical School, 2007-13
    • Professor, Department of Psychiatry and Human Behavior and Department of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, 2013-present

    Research interests

    Our research programs fall into two general categories: (1) Mechanisms underlying drug abuse and dependence, particularly sedative-anxiolytic and stimulant addiction; and (2) cognitive processes as a consequence of aging and metabolic function. We study the pharmacological basis of drug abuse and cognitive processes using in vivo techniques, including self-administration and complex behavior controlled by touch-screen technology. Recently, we have initiated research on the cognitive/behavioral consequences of metabolic disease, including insulin regulation and inflammatory processes. A key component of our research programs is a focus on translational drug discovery, with a long-standing goal of providing important information for discovery and development of anti-addiction, anxiolytic, sleep-aid, and cognitive-enhancing medications.

    Recent publications